Skip to main content
. 2021 Dec 28;23(1):311. doi: 10.3390/ijms23010311

Figure 7.

Figure 7

Schematic representation of the proposed mechanism. E2F2 plays an antiapoptotic function in vivo and in vitro. E2F2 prevents p53-dependent Fas/FasL pathway activation and directly represses Fas and FasL expression in activated T-cells to preserve immune cell homeostasis and protect from immune-mediated tissue injury.